2022 Clinical practice guidelines for central precocious puberty of Korean children and adolescents

키워드

참고문헌 (80)

1. Marshall WA, "Variations in pattern of pubertal changes in girls", Arch Dis Child, 44, pp.291~303 (1969)
2. Kim SH, "A significant increase in the incidence of central precocious puberty among Korean girls from 2004 to 2010", PLoS One, 10, pp.e0141844~ (2015)
3. Kim YJ, "Incidence and prevalence of central precocious puberty in Korea : an epidemiologic study based on a national database", J Pediatr, 208, pp.221~228 (2019)
4. 2011 Clinical Practice Guideline for Korean Children and Adolescents Seoul (Korea), , Korean Society of Pediatric Endocrinology, ~ (2011)
5. McCartney CR, "Obesity and sex steroid changes across puberty : evidence for marked hyperandrogenemia in pre-and early pubertal obese girls", J Clin Endocrinol Metab, 92, pp.430~436 (2007)
6. Li W, "Association between obesity and puberty timing : a systematic review and meta-analysis", Int J Environ Res Public Health, 14, pp.1266~ (2017)
7. Brix N, "Childhood overweight and obesity and timing of puberty in boys and girls : cohort and sibling-matched analyses", Int J Epidemiol, 49, pp.834~844 (2020)
8. de Groot CJ, "Determinants of advanced bone age in childhood obesity", Horm Res Paediatr, 87, pp.254~263 (2017)
9. Deng X, "Association between small fetuses and puberty timing : a systematic review and meta-analysis", Int J Environ Res Public Health, 14, pp.1377~ (2017)
10. Darendeliler F, "IUGR : Genetic influences, metabolic problems, environmental associations", triggers, current and future management, 2019, pp.33, 101260~
11. Verkauskiene R, "Puberty in children born small for gestational age", Horm Res Paediatr, 80, pp.69~77 (2013)
12. Suikkanen J, "Preterm birth and subsequent timing of pubertal growth, menarche, and voice break", Pediatr Res, 92, pp.199~205 (2022)
13. Shim Young Suk, "Genetic factors in precocious puberty", Clinical and Experimental Pediatrics, 65(4), pp.172~181 (2022), 대한소아청소년과학회[DOI]
14. Wohlfahrt-Veje C, "Pubertal onset in boys and girls is influenced by pubertal timing of both parents", J Clin Endocrinol Metab, 101, pp.2667~2674 (2016)
15. Li W, "Association between obesity and puberty timing : a systematic review and meta-analysis", Int J Environ Res Public Health, 14, pp.1266~ (2017)
16. Xu YQ, "Advanced bone age as an indicator facilitates the diagnosis of precocious puberty", J Pediatr(Rio J), 94, pp.69~75 (2018)
17. Freire AV, "High diagnostic accuracy of subcutaneous Triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls", Clin Endocrinol(Oxf), 78, pp.398~404 (2013)
18. 이현영, "The effect of overweight on the luteinizing hormone level after gonadorelin stimulation test in girls with idiopathic central precocious puberty", Annals of Pediatric Endocrinology & Metabolism, 23(4), pp.215~219 (2018), 대한소아내분비학회
19. Neely EK, "Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty", J Pediatr, 127, pp.47~52 (1995)
20. Houk CP, "Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls", Pediatrics, 123, pp.e1059~e1063 (2009)
21. Lee HS, "Utility of Basal luteinizing hormone levels for detecting central precocious puberty in girls", Horm Metab Res, 44, pp.851~854 (2012)
22. 강유선, "Diurnal variation of gonadotropin levels in girls with early stages of puberty", Annals of Pediatric Endocrinology & Metabolism, 22(3), pp.183~188 (2017), 대한소아내분비학회
23. Dong-Min Lee, "Morning basal luteinizing hormone, a good screening tool for diagnosing central precocious puberty", Annals of Pediatric Endocrinology & Metabolism, 24(1), pp.27~33 (2019), 대한소아내분비학회
24. Sathasivam A, "Pelvic ultrasonography in the evaluation of central precocious puberty : comparison with leuprolide stimulation test", J Pediatr, 159, pp.490~495 (2011)
25. Wen X, "Observational study pelvic ultrasound a useful tool in the diagnosis and differentiation of precocious puberty in Chinese girls", Medicine(Baltimore), 97, pp.e0092~ (2018)
26. Nguyen NN, "Diagnostic accuracy of female pelvic ultrasonography in differentiating precocious puberty from premature thelarche : a systematic review and meta-analysis", Front Endocrinol(Lausanne), 12, pp.735875~ (2021)
27. Cantas-Orsdemir S, "Prevalence of cranial MRI findings in girls with central precocious puberty : a systematic review and meta-analysis", J Pediatr Endocrinol Metab, 31, pp.701~710 (2018)
28. 윤종서, "Prevalence of Pathological Brain Lesions in Girls with Central Precocious Puberty: Possible Overestimation?", Journal of Korean Medical Science, 33(51), pp.1~9 (2018), 대한의학회
29. Alikasifoglu A, "Changing etiological trends in male precocious puberty : evaluation of 100 cases with central precocious puberty over the last decade", Horm Res Paediatr, 83, pp.340~344 (2015)
30. Yoon JS, "The prevalence of brain abnormalities in boys with central precocious puberty may be overestimated", PLoS One, 13, pp.e0195209~ (2018)
31. Zhu SY, "An analysis of predictive factors for the conversion from premature thelarche into complete central precocious puberty", J Pediatr Endocrinol Metab, 21, pp.533~538 (2008)
32. Kaplowitz PB, "Toward more targeted and cost-effective gonadotropin-releasing hormone analog treatment in girls with central precocious puberty", Horm Res Paediatr, 90, pp.1~7 (2018)
33. Massart F, "Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty", Neuroendocrinology, 90, pp.307~314 (2009)
34. Franzini IA, "GnRH analog is ineffective in increasing adult height in girls with puberty onset after 7 years of age : a systematic review and meta-analysis", Eur J Endocrinol, 179, pp.381~390 (2018)
35. Bertelloni S, "Adult height after spontaneous pubertal growth or GnRH analog treatment in girls with early puberty : a meta-analysis", Eur J Pediatr, 176, pp.697~704 (2017)
36. Magiakou MA, "The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence : a single center, long-term follow-up study", J Clin Endocrinol Metab, 95, pp.109~117 (2010)
37. Guaraldi F, "Management of endocrine disease : long-term outcomes of the treatment of central precocious puberty", Eur J Endocrinol, 174, pp.R79~R87 (2016)
38. Bangalore Krishna K, "Use of gonadotropin-releasing hormone analogs in children : update by an international consortium", Horm Res Paediatr, 91, pp.357~372 (2019)
39. Calcaterra V, "Rapid progressive central precocious puberty : diagnostic and predictive value of basal sex hormone levels and pelvic ultrasound", J Pediatr Endocrinol Metab, 33, pp.785~791 (2020)
40. Park HK, "Adult height after gonadotropin-releasing hormone agonist treatment in girls with early puberty : a meta-analysis", Clin Endocrinol(Oxf), 93, pp.135~145 (2020)
41. Bertelloni S, "Treatment of central precocious puberty by GnRH analogs : long-term outcome in men", Asian J Androl, 10, pp.525~534 (2008)
42. Kaplowitz PB, "Treatment of central precocious puberty", Curr Opin Endocrinol Diabetes Obes, 16, pp.31~36 (2009)
43. Menk TAS, "Assessment of stress levels in girls with central precocious puberty before and during long-acting gonadotropin-releasing hormone agonist treatment : a pilot study", J Pediatr Endocrinol Metab, 30, pp.657~662 (2017)
44. Copeland W, "Outcomes of early pubertal timing in young women : a prospective population-based study", Am J Psychiatry, 167, pp.1218~1225 (2010)
45. Wojniusz S, "Cognitive, emotional, and psychosocial functioning of girls treated with pharmacological puberty blockage for idiopathic central precocious puberty", Front Psychol, 7, pp.1053~ (2016)
46. Chung Lindsey Yoojin, "Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center", Journal of Korean Medical Science, 36(34), pp.1~9 (2021), 대한의학회[DOI]
47. Jeon Min Jin, "Short-term efficacy of 1-month and 3-month gonadotropin-releasing hormone agonist depots in girls with central precocious puberty", Annals of Pediatric Endocrinology & Metabolism, 26(3), pp.171~177 (2021), 대한소아내분비학회[DOI]
48. Torres-Tamayo M, "Adjuvant interventions in the treatment of precocious puberty : clinical guideline for the diagnosis and treatment of precocious puberty", Bol Med Hosp Infant Mex, 77(Supl 1), pp.26~28 (2020)
49. Carel JC, "Consensus statement on the use of gonadotropin-releasing hormone analogs in children", Pediatrics, 123, pp.e752~e762 (2009)
50. Lee JW, "Significant adverse reactions to long-acting gonadotropinreleasing hormone agonists for the treatment of central precocious puberty and early onset puberty", Ann Pediatr Endocrinol Metab, 19, pp.135~140 (2014)
51. Yeshaya A, "Prolonged vaginal bleeding during central precocious puberty therapy with a long-acting gonadotropin-releasing hormone agonist", Acta Obstet Gynecol Scand, 77, pp.327~329 (1998)
52. Inman M, "Occurrence of slipped capital femoral epiphysis in children undergoing gonadotropin-releasing hormone agonist therapy for the treatment of central precocious puberty", Horm Res Paediatr, 80, pp.64~68 (2013)
53. De Sanctis V, "Long-term effects and significant Adverse Drug Reactions(ADRs)associated with the use of Gonadotropin-Releasing Hormone analogs(GnRHa)for central precocious puberty : a brief review of literature", Acta Biomed, 90, pp.345~359 (2019)
54. Gul U, "Pseudotumour cerebri presentation in a child under the gonadotropin-releasing hormone agonist treatment", J Clin Res Pediatr Endocrinol, 8, pp.365~367 (2016)
55. Omar AA, "Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty", Int J Pediatr Endocrinol, 2020, pp.22~ (2020)
56. Luchinger AB, "Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis", Am J Med Sci, 341, pp.240~242 (2011)
57. Gu Q, "Comparative efficacy and safety of three current clinical treatments for girls with central precocious puberty : a network meta-analysis", Endocr Pract, 25, pp.717~728 (2019)
58. Min Sub Kim, "Comparing adult height gain and menarcheal age between girls with central precocious puberty treated with gonadotropin-releasing hormone agonist alone and those treated with combined growth hormone therapy", Annals of Pediatric Endocrinology & Metabolism, 24(2), pp.116~123 (2019), 대한소아내분비학회[DOI]
59. Klein KO, "Predictors of bone maturation, growth rate and adult height in children with central precocious puberty treated with depot leuprolide acetate", J Pediatr Endocrinol Metab, 31, pp.655~663 (2018)
60. Zurita-Cruz JN, "Monitoring during the treatment of precocious puberty : clinical guideline for the diagnosis and treatment of precocious puberty", Bol Med Hosp Infant Mex, 77(Supl 1), pp.29~34 (2020)
61. Lazar L, "Pubertal disorders and bone maturation", Endocrinol Metab Clin North Am, 41, pp.805~825 (2012)
62. Brito VN, "A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls", J Clin Endocrinol Metab, 89, pp.4338~4342 (2004)
63. Lee PA, "Efficacy and safety of leuprolide acetate 3-month depot 11. 25 milligrams or 30 milligrams for the treatment of central precocious puberty", J Clin Endocrinol Metab, 97, pp.1572~1580 (2012)
64. Lazar L, "Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity", J Clin Endocrinol Metab, 92, pp.3483~3489 (2007)
65. Brito VN, "Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs", J Clin Endocrinol Metab, 93, pp.2662~2669 (2008)
66. Eugster EA, "Treatment of central precocious puberty", J Endocr Soc, 3, pp.965~972 (2019)
67. Shim YS, "Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty", PLoS One, 15, pp.e0243212~ (2020)
68. Carel JC, "Final height after long-term treatment with triptorelin slow release for central precocious puberty : importance of statural growth after interruption of treatment. French study group of Decapeptyl in Precocious Puberty", J Clin Endocrinol Metab, 84, pp.1973~1978 (1999)
69. Wu Vickie, "Clinical findings influencing time to menarche post gonadotropin-releasing hormone agonist therapy in central precocious puberty", Annals of Pediatric Endocrinology & Metabolism, 26(3), pp.185~191 (2021), 대한소아내분비학회[DOI]
70. Heger S, "Long-term outcome after depot gonadotropin-releasing hormone agonist treatment of central precocious puberty : final height, body proportions, body composition, bone mineral density, and reproductive function", J Clin Endocrinol Metab, 84, pp.4583~4590 (1999)
71. Lazar L, "Treated and untreated women with idiopathic precocious puberty : BMI evolution, metabolic outcome, and general health between third and fifth decades", J Clin Endocrinol Metab, 100, pp.1445~1451 (2015)
72. Martinerie L, "Fertility of women treated during childhood with Triptorelin(depot formulation)for central precocious puberty : the PREFER study", Horm Res Paediatr, 93, pp.529~538 (2020)
73. Bertelloni S, "Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropinreleasing hormone analogues", Eur J Pediatr, 159, pp.369~374 (2000)
74. Lazar L, "Treated and untreated women with idiopathic precocious puberty : long-term follow-up and reproductive outcome between the third and fifth decades", Clin Endocrinol(Oxf), 80, pp.570~576 (2014)
75. Luo X, "Long-term efficacy and safety of gonadotropin-releasing hormone analog treatment in children with idiopathic central precocious puberty : a systematic review and meta-analysis", Clin Endocrinol(Oxf), 94, pp.786~796 (2021)
76. 윤종완, "The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty", Clinical and Experimental Pediatrics, 60(12), pp.395~402 (2017), 대한소아청소년과학회
77. van der Sluis IM, "Longitudinal follow-up of bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy", J Clin Endocrinol Metab, 87, pp.506~512 (2002)
78. Park HK, "The effect of gonadotrophin-releasing hormone agonist treatment over 3 years on bone mineral density and body composition in girls with central precocious puberty", Clin Endocrinol(Oxf), 77, pp.743~748 (2012)
79. Antoniazzi F, "Bone development during GH and GnRH analog treatment", Eur J Endocrinol, 151(Suppl 1), pp.S47~S54 (2004)
80. Prentice P, "Pubertal timing and adult obesity and cardiometabolic risk in women and men : a systematic review and meta-analysis", Int J Obes(Lond), 37, pp.1036~1043 (2013)